Evaluation of clinical and genetic indicators for the early response to intravitreal ranibizumab in exudative age-related macular degeneration. [electronic resource]
Producer: 20150113Description: 833-43 p. digitalISSN:- 1744-8042
- Aged
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Asian People -- genetics
- Complement Factor H -- genetics
- Female
- Humans
- Intravitreal Injections -- methods
- Macular Degeneration -- drug therapy
- Male
- Polymorphism, Single Nucleotide -- genetics
- Proteins -- genetics
- Ranibizumab
- Retina -- drug effects
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.